GENZ - the stock that keeps on giving

GENZ it went up another few dollars...what a quinkydink, right after my father got a shot of Synvisc in the knee the other day. I would like to quote him after his shot- (I swear he really said this): "every since I got the shot of synvisc i have no pain in my knee anymore".

anyway, hope you all can get in on the action...

By MarketWatchLast Update: 5:32 PM ET May 5, 2005
CAMBRIDGE, Mass. (MarketWatch) -- Genzyme Corp. (GENZ) said a clinical review of its oesteoarthritis product Synvisc showed the product was effective.

In a press release Wednesday, the company said that since it is delivered locally, Synvisc avoids many of the associated side-effects of traditional nonsteroidal anti-inflammatory drugs and COX-2 agents. Synvisc is used for the treatment of pain due to osteoarthritis of the knee.
The pharmaceutical company said a review examining the clinical benefits of Synvisc and the class of viscosupplements to which it belongs has been published by the Cochrane Collaboration, an independent, international organization that disseminates systematic reviews of healthcare interventions and clinical trials data.
The Cochrane Collaboration review concluded the class of viscosupplements is superior to placebo and that several of the products have greater efficacy than steroid injections in treating pain associated with osteoarthritis of the knee. Viscosupplements are a kind of injectable product. Genzyme shares recently traded at $62.92, up $2.90, or 4.8%